Navigation Links
Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
Date:8/16/2011

EAST BRUNSWICK, N.J., Aug. 16, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today announced that results from two pivotal KRYSTEXXA® (pegloticase) Phase III clinical studies in patients with refractory chronic gout (RCG) have been published in The Journal of the American Medical Association (JAMA). The data demonstrated that treatment with KRYSTEXXA resulted in significant and sustained reductions in uric acid levels along with clinical improvements in a substantial proportion of RCG patients for six months, a timeframe for demonstrating clinical improvement that is unique in randomized controlled studies of urate-lowering therapies.

The two replicate, randomized, double-blind, placebo-controlled Phase III studies were designed to evaluate the efficacy and tolerability of treatment with KRYSTEXXA 8 mg every two weeks or every four weeks compared to placebo for the management of RCG patients. Pooled results from these studies demonstrated that treatment with KRYSTEXXA every two weeks, the U.S. Food and Drug Administration (FDA)-approved dose, resulted in a statistically significant and sustained reduction in uric acid levels below 6 mg/dL in 42 percent of patients, compared to zero percent of patients receiving placebo (p<0.001).  

In addition, 40 percent of patients with tophi receiving KRYSTEXXA every two weeks experienced complete resolution of one or more tophi, which are deposits of crystalline urate in joints, skin or cartilage, by the final study visit, compared to seven percent of patients on placebo (p=0.002). A tophus complete response was defined as 100 percent reduction in the measured area of at least one tophus without growth of any baseline tophus or appearance of any new tophus.

"When effective lowering of uric acid levels cannot be achieved with oral medications, many gout patients progress to a se
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Savient Pharmaceuticals to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
2. Savient Pharmaceuticals Reports Second Quarter 2011 Financial Results
3. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
4. Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency
5. Savient Pharmaceuticals Reports First Quarter 2011 Financial Results
6. Savient Pharmaceuticals Submits European Marketing Authorization Application for KRYSTEXXA®
7. Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
8. Savient Pharmaceuticals to Present Multiple Abstracts at The European League Against Rheumatism (EULAR) 2011 Annual Congress
9. Savient Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
10. Savient Pharmaceuticals to Hold First Quarter 2011 Financial Results
11. Savient Pharmaceuticals to Present at the ROTH 23rd Annual OC Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014   Zacks Equity Research highlights ... of the Day and Panera (Nasdaq: PNRA - Free Report ... Research provides analysis on Amicus Therapeutics (Nasdaq: FOLD - Free ... Shire (Nasdaq: SHPG - Free Report ). Here ... Bull of the Day : The biotech bull ...
(Date:8/22/2014)... 2014  Cannabis Science, Inc. (OTC: CBIS), a ... and related consulting, is pleased to announce its ... conference taking place at the Faculty of Medicine ... October 22, 2014.  The multilingual conference brings together ... health professionals, and patients, to discuss the development ...
(Date:8/21/2014)... Hermann Health System and The University of Texas ... to provide a new level of specialized breast screening at ... Houston area. Starting in ... professional breast radiology services for five of Memorial Hermann,s 10 ... Woodlands , Northeast, Southwest and Sugar Land ...
Breaking Medicine Technology:Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 4Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 5Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 6Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4
... Steve Hoffman, Chief Executive Officer of iJET ... intelligence and business resiliency services, will present information ... Continuity Insights 2011 Management Conference. Introducing a case ... where defects and delays could be life-threatening to ...
... April 5, 2011 Practice Fusion, the fastest ... a $23 million Series B round of financing ... Capital Management and Glynn Capital Management, as well ... The round brings the company,s total funding to ...
Cached Medicine Technology:iJET to Lead Discussion on Supplier Resiliency at Continuity Insights Management Conference 2Founders Fund Leads $23 Million Practice Fusion Financing Round 2Founders Fund Leads $23 Million Practice Fusion Financing Round 3Founders Fund Leads $23 Million Practice Fusion Financing Round 4Founders Fund Leads $23 Million Practice Fusion Financing Round 5
(Date:8/22/2014)... with severe disabilities and multiple chronic conditions are screened ... disabilities or no chronic conditions, a new study has ... women with moderate disabilities or women with only one ... scientist with the Li Ka Shing Knowledge Institute of ... disabilities often have other measures of social vulnerability, such ...
(Date:8/22/2014)... NY (PRWEB) August 22, 2014 Ticket ... Caputo tickets in Kalamazoo, New Orleans, Albuquerque and Rapid ... death, the “Long Island Medium,” Theresa Caputo, allows just that. ... Island. She is part of a close knit family who ... speaking with a spiritual healer, realized she had a chance ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 “Dr. Luciana Show ... Lagana , aka Dr. Luciana, is finding it challenging to ... and while taking care of hundreds of students, so the ... for the show is completed, and she recently entered it ... projects including those of her husband, actor/screenwriter Gregory Graham ...
(Date:8/22/2014)... (ESMO), the leading pan-European organisation representing medical oncology ... individuals receiving the Society,s esteemed annual awards. The ... Joensuu and Peter Boyle on the occasion of ... , Carsten Bokemeyer will receive the ESMO Award ... cancer discovery into real benefit at patient level. ...
(Date:8/22/2014)... difficulties, fainting. Each year approx. 265,000 Danes are acutely ... New research from Aarhus University and Aarhus University Hospital ... as every fourth patient are sent home again ... led to the acute hospitalisation., "Naturally, there is no ... hospital disprove that there is a serious illness. So ...
Breaking Medicine News(10 mins):Health News:Women with severe, chronic health issues are screened for breast cancer less often 2Health News:Theresa Caputo Tickets in Kalamazoo at Wings Stadium, Saenger Theatre in New Orleans, Kiva Auditorium in Albuquerque and Rapid City at Don Barnett Arena Now Available 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 3Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 4Health News:ESMO honors outstanding oncology professionals 2Health News:ESMO honors outstanding oncology professionals 3Health News:Many patients are discharged without a diagnosis 2
... , , SAN FRANCISCO , ... Watson Pharmaceuticals, Inc. (NYSE: WPI ) today announced that it ... to more than $2.7 billion for 2009, compared to 2008, ... meet or exceed the forecast the Company provided in November 2009 ...
... , , MISSION, Kan. , ... administrator, announces the launch of a Third Party Administrator ... put into action under the TPA,s own brand, allowing ... expertise without sacrificing the consultative client connection. Services include ...
... reduced secondary lymphedema in study patients , WEDNESDAY, Jan. ... cancer surgery can be prevented or reduced if patients ... after their operation, a new study suggests. , Secondary ... during treatment -- results in fluid retention and arm ...
... ... product design, precision manufacturing and assembly, and its ability to provide medical components ... ... 13, 2010 -- Airtronics Metal Products, a sheet metal design, engineering ...
... OAKLAND, Calif. , Jan. 13 The nation,s ... relief program to recruit nurse volunteers to provide assistance to ... United announced Tuesday night. , Registered Nurse Response Network sent ... following Hurricane Katrina. RNRN has also sent volunteers to ...
... ... in Salt Lake City and the surrounding region, recently hosted top cataract surgeons from around ... In a live TV event, the surgeons performed free cataract surgery on a group of selected ... ...
Cached Medicine News:Health News:Watson Announces Preliminary Financial Performance for FY 2009 2Health News:Watson Announces Preliminary Financial Performance for FY 2009 3Health News:Watson Announces Preliminary Financial Performance for FY 2009 4Health News:Watson Announces Preliminary Financial Performance for FY 2009 5Health News:New Program Provides COBRA Relief for Third Party Administrators 2Health News:New Program Provides COBRA Relief for Third Party Administrators 3Health News:Therapy May Relieve Breast Cancer Surgery Complication 2Health News:Airtronics Metal Products Earns ISO 13485 Certification 2Health News:Largest RN Union Issues Urgent Call for Nurse Volunteers to Assist Earthquake Ravaged Haiti 2Health News:The Eye Institute of Utah Hosts World Renowned Cataract Surgeons: In Economically Trying Times, Nine Fortunate Patients Receive State of the Art Cataract Lenses 2Health News:The Eye Institute of Utah Hosts World Renowned Cataract Surgeons: In Economically Trying Times, Nine Fortunate Patients Receive State of the Art Cataract Lenses 3
Provides maximum comfort upon insertion through ultra-smooth catheter eyelets--formed with advanced ultrasonic technology....
... in four convenient formats to meet all ... custom draping for any surgical procedure. All ... billowing up. , ,The precision, die-cut holes ... layer is soft against the patient's skin. ...
Convective Air Warming Blankets...
... CSZ safely provides effective air warming therapy ... patented design of our WarmAir® FilteredFlo® blankets, ... which supplies gently moving, clean air that ... contaminants to your patient or staff. All ...
Medicine Products: